Nex-T TM Cluster of Differentiation 19 (CD19) Chimeric Antigen Receptor (CAR) T-Cell Therapy BMS-986353 (CC-97540): Comparative Analysis of Baseline Patient Data from Trials in Systemic Lupus Erythematosus (SLE) and Relapsed/Refractory Large B-Cell Lymphoma (R/R LBCL) Related to Manufacturability and Potential Safety
Fabian Mueller(German Cancer Research Center), Georg Schett(Karolinska University Hospital), Thomas Wegman(Bristol-Myers Squibb (United States)), Ashley K. Koegel(Bristol-Myers Squibb (United States)), Nikolay Delev(Bristol-Myers Squibb (Sweden)), Yanhua Hu(First Affiliated Hospital Zhejiang University), Vaishali Shah(Bristol-Myers Squibb (United States)), Julie Rytlewski(Adaptive Biotechnologies (United States)), Ana Kostić(Agriculture and Agri-Food Canada), Chun‐Ying Wu(National Yang Ming Chiao Tung University)
Cited by 0
Related Papers
Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin
|Journal of Clinical Investigation|2012|708
EULAR definition of difficult-to-treat rheumatoid arthritis
|Annals of the Rheumatic Diseases|2020|538